The ElmediX' thermal therapy, as part of hyperthermia treatments, is a new cancer treatment modality.
ElmediX strives to improve and extend the lives of cancer patients worldwide.
ElmediX offers hope for cancer patients by using thermal therapy.
Through the innovative, reliable and medical-scientifically based treatment, the life expectancy and quality of life of these patients can possibly be improved.
ElmediX is developing an innovative thermal therapy without significant clinical side effects (toxicity) and with a high effectiveness.
More information about this can be found here.
ElmediX offers hope for cancer patients by using thermal therapy. This innovative treatment can possibly extend the life expectancy and improve the quality of life.
The therapy has been developed and tested very carefully thanks to the integrity, involvement and expertise of the ElmediX team.
The test results are promising and align to the company mission.
Together with healthcare providers and investors, we strive to extend the life of cancer patients and improve their quality of life.
Strong values determine our corporate culture and help us realize the mission and vision of ElmediX.
We stand for:
Reliability
Integrity
Involvement
ElmediX was founded in 2015 as a spin-off company of the University of Antwerp with one goal: to develop a disruptive solution for (pancreatic) cancer and other life-threatening diseases. The ElmediX team brings this mission to life.
Are you curious how?
